Tirzepatide: The weight-loss drug that also shrinks breast tumors in mice

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast cancer growth in a mouse model, according to a study being presented at ENDO 2025, the Endocrine Society’s…

Continue Reading